The global market for Synthetic Biology in Medical is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Synthetic Biology in Medical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Synthetic Biology in Medical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Synthetic Biology in Medical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Synthetic Biology in Medical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Synthetic Biology in Medical players cover Thermo Fisher Scientific, Novozymes, Merck KGaA, Agilent Technologies and Arzeda, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This latest report provides a deep insight into the global Synthetic Biology in Medical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Synthetic Biology in Medical market, with both quantitative and qualitative data, to help readers understand how the Synthetic Biology in Medical market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
The study segments the Synthetic Biology in Medical market and forecasts the market size by Type (Genome Engineering, NGS and Cloning and Sequencing), by Application (Drug Discovery And Therapeutics, Pharmaceuticals and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Cloning and Sequencing
Segmentation by application
Drug Discovery And Therapeutics
Segmentation by region
Middle East & Africa
Major companies covered
Thermo Fisher Scientific
Genscript Biotech Corp
Integrated DNA Technologies
New England Biolabs
Chapter 1: Scope of Synthetic Biology in Medical, Research Methodology, etc.
Chapter 2: Executive Summary, global Synthetic Biology in Medical market size and CAGR, Synthetic Biology in Medical market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Synthetic Biology in Medical revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Synthetic Biology in Medical revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Synthetic Biology in Medical market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Thermo Fisher Scientific, Novozymes, Merck KGaA, Agilent Technologies, Arzeda, Codexis, Ginkgo Bioworks, Precigen and Genscript Biotech Corp, etc.
Chapter 14: Research Findings and Conclusion